Best Pyrimidine Synthesis Inhibitor for multiple sclerosis, relapsing-remitting
2 Pyrimidine Synthesis Inhibitor drugs indicated for multiple sclerosis, relapsing-remitting, ranked by our independent rating. The current highest-rated is teriflunomide. Compare them with all treatments for multiple sclerosis, relapsing-remitting or the full Pyrimidine Synthesis Inhibitor class. Not medical advice — always consult a professional.
Top pyrimidine synthesis inhibitor for multiple sclerosis, relapsing-remitting: 1. Teriflunomide · 2. Aubagio
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Teriflunomide | 46/100 | Prescription | $19 | View → |
| 2 | Aubagio | Not yet rated | Prescription | $19 | View → |
Full ranking · 2 drugs
Frequently asked
- What is the best pyrimidine synthesis inhibitor for multiple sclerosis, relapsing-remitting?
- By our independent rating, teriflunomide currently ranks highest among Pyrimidine Synthesis Inhibitor drugs used for multiple sclerosis, relapsing-remitting. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which pyrimidine synthesis inhibitor drugs treat multiple sclerosis, relapsing-remitting?
- pharmaranks lists 2 Pyrimidine Synthesis Inhibitor products indicated for multiple sclerosis, relapsing-remitting, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
